144 related articles for article (PubMed ID: 37457220)
41. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
Wen J; Chen W; Zhu Y; Zhang P
BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
[TBL] [Abstract][Full Text] [Related]
42. Global Landscape of Glioblastoma Multiforme Management in the Stupp Protocol Era: Systematic Review Protocol.
Adegboyega G; Kanmounye US; Petrinic T; Ozair A; Bandyopadhyay S; Kuri A; Zolo Y; Marks K; Ramjee S; Baticulon RE; Vaqas B;
Int J Surg Protoc; 2021 Jun; 25(1):108-113. PubMed ID: 34222733
[TBL] [Abstract][Full Text] [Related]
43. Glioblastoma Survival Outcomes at a Tertiary Hospital in Appalachia: Factors Impacting the Survival of Patients Following Implementation of the Stupp Protocol.
Urhie O; Turner R; Lucke-Wold B; Radwan W; Ahn J; Gyure K; Bhatia S
World Neurosurg; 2018 Jul; 115():e59-e66. PubMed ID: 29631083
[TBL] [Abstract][Full Text] [Related]
44. Effectiveness of radiotherapy for elderly patients with glioblastoma.
Scott J; Tsai YY; Chinnaiyan P; Yu HH
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):206-10. PubMed ID: 20675068
[TBL] [Abstract][Full Text] [Related]
45. Treatment approach and survival from glioblastoma: results from a population-based retrospective cohort study from Western Norway.
Bjorland LS; Fluge O; Gilje B; Mahesparan R; Farbu E
BMJ Open; 2021 Mar; 11(3):e043208. PubMed ID: 33712524
[TBL] [Abstract][Full Text] [Related]
46. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.
Jeon HJ; Kong DS; Park KB; Lee JI; Park K; Kim JH; Kim ST; Lim DH; Kim WS; Nam DH
Clin Neurol Neurosurg; 2009 Oct; 111(8):679-82. PubMed ID: 19640635
[TBL] [Abstract][Full Text] [Related]
47. Permanent iodine-125 interstitial radiation therapy in the treatment of non-glioblastoma multiforme high-grade gliomas.
Zamorano L; Li Q; Tekyi-Mensah S; Gaspar L; Fontanesi J; Levin K
Stereotact Funct Neurosurg; 2003; 81(1-4):10-7. PubMed ID: 14742958
[TBL] [Abstract][Full Text] [Related]
48. Results of Treating Childhood Acute Lymphoblastic Leukemia in a Low-middle Income Country: 10 Year Experience in Northeast Mexico.
Jaime-Pérez JC; López-Razo ON; García-Arellano G; Pinzón-Uresti MA; Jiménez-Castillo RA; González-Llano O; Gómez-Almaguer D
Arch Med Res; 2016 Nov; 47(8):668-676. PubMed ID: 28476194
[TBL] [Abstract][Full Text] [Related]
49. Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy.
Kreth FW; Thon N; Simon M; Westphal M; Schackert G; Nikkhah G; Hentschel B; Reifenberger G; Pietsch T; Weller M; Tonn JC;
Ann Oncol; 2013 Dec; 24(12):3117-23. PubMed ID: 24130262
[TBL] [Abstract][Full Text] [Related]
50. The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: a simulation-based analysis.
Ward ZJ; Atun R; Hricak H; Asante K; McGinty G; Sutton EJ; Norton L; Scott AM; Shulman LN
Lancet Oncol; 2021 Sep; 22(9):1301-1311. PubMed ID: 34416159
[TBL] [Abstract][Full Text] [Related]
51. Social determinants of health and survival on Brazilian patients with glioblastoma: a retrospective analysis of a large populational database.
Marta GN; Moraes FY; Feher O; Vellutini EAS; Pahl FH; Gomes MQT; Cardoso ACC; Neville IS; Hanna SA; Palhares DMF; Teixeira MJ; Maldaun MVC; Pereira AAL
Lancet Reg Health Am; 2021 Dec; 4():100066. PubMed ID: 36776713
[TBL] [Abstract][Full Text] [Related]
52. Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base.
Amsbaugh MJ; Yusuf MB; Gaskins J; Burton EC; Woo SY
Cancer; 2017 Sep; 123(17):3277-3284. PubMed ID: 28452053
[TBL] [Abstract][Full Text] [Related]
53. Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.
Stupp R; Taillibert S; Kanner AA; Kesari S; Steinberg DM; Toms SA; Taylor LP; Lieberman F; Silvani A; Fink KL; Barnett GH; Zhu JJ; Henson JW; Engelhard HH; Chen TC; Tran DD; Sroubek J; Tran ND; Hottinger AF; Landolfi J; Desai R; Caroli M; Kew Y; Honnorat J; Idbaih A; Kirson ED; Weinberg U; Palti Y; Hegi ME; Ram Z
JAMA; 2015 Dec; 314(23):2535-43. PubMed ID: 26670971
[TBL] [Abstract][Full Text] [Related]
54. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
[TBL] [Abstract][Full Text] [Related]
55. Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525.
Shi W; Scannell Bryan M; Gilbert MR; Mehta MP; Blumenthal DT; Brown PD; Valeinis E; Hopkins K; Souhami L; Andrews DW; Tzuk-Shina T; Howard SP; Youssef EF; Lessard N; Dignam JJ; Werner-Wasik M
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):38-44. PubMed ID: 29102648
[TBL] [Abstract][Full Text] [Related]
56. Association of molecular marker O(6)Methylguanine DNA methyltransferase and concomitant chemoradiotherapy with survival in Southern Chinese glioblastoma patients.
Chan DT; Kam MK; Ma BB; Ng SC; Pang JC; Lau CK; Siu DY; Ng BS; Zhu XL; Chen GG; Ng HK; Poon WS
Hong Kong Med J; 2011 Jun; 17(3):184-8. PubMed ID: 21636865
[TBL] [Abstract][Full Text] [Related]
57. Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database.
Blumenthal DT; Won M; Mehta MP; Gilbert MR; Brown PD; Bokstein F; Brachman DG; Werner-Wasik M; Hunter GK; Valeinis E; Hopkins K; Souhami L; Howard SP; Lieberman FS; Shrieve DC; Wendland MM; Robinson CG; Zhang P; Corn BW
Neuro Oncol; 2018 Jun; 20(7):966-974. PubMed ID: 29462493
[TBL] [Abstract][Full Text] [Related]
58. Global Retinoblastoma Treatment Outcomes: Association with National Income Level.
Tomar AS; Finger PT; Gallie B; Kivelä TT; Mallipatna A; Zhang C; Zhao J; Wilson MW; Brenna RC; Burges M; Kim J; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català J; Correa-Llano G; Carreras E;
Ophthalmology; 2021 May; 128(5):740-753. PubMed ID: 33007338
[TBL] [Abstract][Full Text] [Related]
59. Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.
Sun MZ; Oh T; Ivan ME; Clark AJ; Safaee M; Sayegh ET; Kaur G; Parsa AT; Bloch O
J Neurosurg; 2015 May; 122(5):1144-50. PubMed ID: 25768833
[TBL] [Abstract][Full Text] [Related]
60. Is Treatment at a High-volume Center Associated with an Improved Survival for Primary Malignant Bone Tumors?
Malik AT; Alexander JH; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Mar; 478(3):631-642. PubMed ID: 31714413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
